Shun Ishibashi
#160,896
Most Influential Person Now
Researcher
Shun Ishibashi's AcademicInfluence.com Rankings
Shun Ishibashicomputer-science Degrees
Computer Science
#9234
World Rank
#9701
Historical Rank
Machine Learning
#3990
World Rank
#4038
Historical Rank
Artificial Intelligence
#4325
World Rank
#4385
Historical Rank
Database
#6210
World Rank
#6440
Historical Rank
Download Badge
Computer Science
Shun Ishibashi's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Shun Ishibashi Influential?
(Suggest an Edit or Addition)Shun Ishibashi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. (1993) (1555)
- A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection (1997) (1240)
- Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. (1994) (739)
- Sterol Regulatory Element-binding Protein-1 as a Key Transcription Factor for Nutritional Induction of Lipogenic Enzyme Genes* (1999) (675)
- High cholesterol level is essential for myelin membrane growth (2005) (613)
- Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. (2000) (568)
- Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter (2001) (526)
- The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. (1994) (453)
- Polyunsaturated Fatty Acids Suppress Sterol Regulatory Element-binding Protein 1c Promoter Activity by Inhibition of Liver X Receptor (LXR) Binding to LXR Response Elements* (2002) (423)
- Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 (2018) (421)
- Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP‐1 suppression (2003) (404)
- A Crucial Role of Sterol Regulatory Element-binding Protein-1 in the Regulation of Lipogenic Gene Expression by Polyunsaturated Fatty Acids* (1999) (369)
- Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes DOI 10.1194/jlr.M100417-JLR200 (2002) (353)
- Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance inLep ob /Lep ob Mice* (2002) (351)
- Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice: Pleiotropic Effects on CD36 Expression and HDL (2001) (344)
- Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. (2003) (331)
- Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. (1994) (313)
- Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2013) (312)
- Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control (2006) (287)
- Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. (2014) (283)
- Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. (2003) (273)
- Dual regulation of mouse Δ5- and Δ6-desaturase gene expression by SREBP-1 and PPARα (2002) (264)
- Promoter Analysis of the Mouse Sterol Regulatory Element-binding Protein-1c Gene* (2000) (252)
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study (2018) (244)
- Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. (1998) (238)
- Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. (1996) (232)
- Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. (2005) (229)
- Severe Hypercholesterolemia, Hypertriglyceridemia, and Atherosclerosis in Mice Lacking Both Leptin and the Low Density Lipoprotein Receptor* (2001) (220)
- Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. (2004) (202)
- p53 Activation in Adipocytes of Obese Mice* (2003) (197)
- Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. (2003) (191)
- FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products* (2003) (187)
- Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. (2002) (187)
- Absence of ACAT-1 Attenuates Atherosclerosis but Causes Dry Eye and Cutaneous Xanthomatosis in Mice with Congenital Hyperlipidemia* (2000) (182)
- Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2014) (181)
- Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. (1987) (178)
- Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. (1990) (176)
- Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats. (2004) (175)
- Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). (2011) (166)
- Guidelines for the management of familial hypercholesterolemia. (2012) (163)
- Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. (2003) (163)
- Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins (2010) (160)
- Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. (1998) (157)
- Sterol Regulatory Element-binding Protein-1 Is Regulated by Glucose at the Transcriptional Level* (2000) (152)
- Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. (1996) (150)
- Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. (2005) (149)
- Diagnostic criteria for dyslipidemia. (2013) (137)
- Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. (2002) (136)
- Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. (1990) (133)
- Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017 (2018) (132)
- Role of the Low Density Lipoprotein (LDL) Receptor Pathway in the Metabolism of Chylomicron Remnants (1996) (128)
- Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study) (2010) (127)
- Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. (2003) (127)
- Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory Circuit* (2010) (124)
- p53 Involvement in the Pathogenesis of Fatty Liver Disease* (2004) (124)
- Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. (1986) (123)
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial. (2016) (123)
- Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. (1999) (117)
- Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. (1991) (115)
- Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. (2002) (114)
- Early Embryonic Lethality Caused by Targeted Disruption of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Gene* (2003) (112)
- Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. (2002) (111)
- SREBP-1-independent regulation of lipogenic gene expression in adipocytes Published, JLR Papers in Press, April 24, 2007. (2007) (109)
- Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial (2018) (106)
- Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. (1994) (105)
- Identification of Neutral Cholesterol Ester Hydrolase, a Key Enzyme Removing Cholesterol from Macrophages* (2008) (104)
- Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. (2009) (104)
- Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis. (2004) (101)
- The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice. (2014) (99)
- Involvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance (2007) (99)
- RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. (2008) (98)
- Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial. (2017) (96)
- Large scale replication analysis of loci associated with lipid concentrations in a Japanese population (2009) (94)
- Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. (2000) (91)
- Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan. (2004) (87)
- The Critical Role of Neutral Cholesterol Ester Hydrolase 1 in Cholesterol Removal From Human Macrophages (2010) (85)
- Statins Augment Collateral Growth in Response to Ischemia but They Do Not Promote Cancer and Atherosclerosis (2004) (84)
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
- Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia. (2017) (83)
- Enhanced Expression of Platelet-Derived Growth Factor-β Receptor by High Glucose Involvement of Platelet-Derived Growth Factor in Diabetic Angiopathy (1996) (81)
- Diagnosis and management of type I and type V hyperlipoproteinemia. (2012) (81)
- Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits. (1989) (79)
- The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. (2006) (78)
- Plasma apolipoproteins in patients with multi-infarct dementia. (1989) (77)
- Pyripyropene A, an Acyl–Coenzyme A: Cholesterol Acyltransferase 2–Selective Inhibitor, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia (2011) (76)
- Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. (2004) (75)
- Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. (1991) (75)
- Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. (1990) (71)
- Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance (1999) (70)
- Identification of a Novel Member of the Carboxylesterase Family That Hydrolyzes Triacylglycerol (2006) (70)
- A single nucleotide polymorphism in the FADS1/FADS2 gene is associated with plasma lipid profiles in two genetically similar Asian ethnic groups with distinctive differences in lifestyle (2010) (69)
- Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial (2018) (68)
- Asialoglycoprotein Receptor Deficiency in Mice Lacking the Major Receptor Subunit (2001) (67)
- Lipoprotein(a) and atherosclerosis. (2001) (65)
- The Major Subunit of the Asialoglycoprotein Receptor Is Expressed on the Hepatocellular Surface in Mice Lacking the Minor Receptor Subunit* (1996) (65)
- Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. (2013) (64)
- The role of neutral cholesterol ester hydrolysis in macrophage foam cells. (2011) (63)
- Bcl‐2 protein inhibits oxysterol‐induced apoptosis through suppressing CPP32‐mediated pathway (1997) (63)
- Human monocyte colony-stimulating factor enhances the clearance of lipoproteins containing apolipoprotein B-100 via both low density lipoprotein receptor-dependent and -independent pathways in rabbits. (1990) (62)
- Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice. (2012) (60)
- Absence of Hormone-sensitive Lipase Inhibits Obesity and Adipogenesis in Lepob/ob Mice* (2004) (59)
- Scavenger Receptor Expressed by Endothelial Cells I (SREC-I) Mediates the Uptake of Acetylated Low Density Lipoproteins by Macrophages Stimulated with Lipopolysaccharide* (2004) (58)
- A single bout of exercise at higher intensity enhances glucose effectiveness in sedentary men. (2005) (58)
- Effect of moderate exercise training on peripheral glucose effectiveness, insulin sensitivity, and endogenous glucose production in healthy humans estimated by a two-compartment-labeled minimal model. (2004) (56)
- Regulatory SNP in the RBP4 Gene Modified the Expression in Adipocytes and Associated With BMI (2010) (56)
- Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS) (2013) (55)
- Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity (2013) (55)
- Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy. (2015) (54)
- Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. (2008) (53)
- HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes. (2002) (51)
- Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency. (2003) (51)
- Adrenal Neutral Cholesteryl Ester Hydrolase: Identification, Subcellular Distribution, and Sex Differences. (2002) (49)
- Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model. (2007) (48)
- Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes (2012) (47)
- [LDL-receptor-related protein]. (1994) (46)
- Resistance to Neointimal Hyperplasia and Fatty Streak Formation in Mice With Adrenomedullin Overexpression (2002) (45)
- Na/H Exchange Isoform 1 Is Involved in Mineralocorticoid/Salt-Induced Cardiac Injury (2003) (45)
- The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin (2015) (44)
- Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012. (2013) (43)
- Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes. (2010) (43)
- Long-range negative correlation of glucose dynamics in humans and its breakdown in diabetes mellitus. (2006) (40)
- Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-gamma and macrophage colony-stimulating factor in human aortic medial smooth muscle cells. (1995) (39)
- Leptin inhibits and ghrelin augments hypothalamic noradrenaline release after stress (2008) (39)
- Elimination of Cholesterol Ester from Macrophage Foam Cells by Adenovirus-mediated Gene Transfer of Hormone-sensitive Lipase* (2002) (39)
- Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver Published, JLR Papers in Press, June 1, 2006. (2006) (39)
- Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study (2018) (38)
- Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability? (2008) (38)
- Liver-Specific Deletion of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Causes Hepatic Steatosis and Death (2012) (38)
- Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment (2019) (38)
- Depot-specific expression of lipolytic genes in human adipose tissues--association among CES1 expression, triglyceride lipase activity and adiposity. (2011) (37)
- Long-range Correlated Glucose Fluctuations in Diabetes (2007) (37)
- Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency. (1991) (36)
- Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence[S] (2010) (35)
- The LDL receptor is not necessary for acute adrenal steroidogenesis in mouse adrenocortical cells. (2007) (35)
- Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--. (2004) (34)
- Comparison of pioglitazone and metformin efficacy using homeostasis model assessment (2004) (33)
- Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). (2009) (32)
- A case of thymic enlargement in hyperthyroidism in a young woman. (2004) (32)
- Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes. (2001) (32)
- High mobility group protein-B1 interacts with sterol regulatory element-binding proteins to enhance their DNA binding. (2005) (32)
- Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. (1995) (31)
- Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia. (2018) (31)
- Pioglitazone‐induced hepatic injury in a patient previously receiving troglitazone with success (2002) (31)
- Induction of Macrophage Colony-stimulating Factor Receptor (c-fms) Expression in Vascular Medial Smooth Muscle Cells Treated with Heparin Binding Epidermal Growth Factor-like Growth Factor* (1996) (31)
- The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus (2012) (30)
- Rapid genotyping of low density lipoprotein receptor knockout mice using a polymerase chain reaction technique (1995) (30)
- Ligand‐independent activation of vascular endothelial growth factor receptor 1 by low‐density lipoprotein (2007) (30)
- Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. (2017) (29)
- Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages[S] (2014) (29)
- Pitavastatin decreases plasma prebeta1-HDL concentration and might promote its disappearance rate in hypercholesterolemic patients. (2008) (28)
- Effects of human recombinant macrophage colony-stimulating factor on the secretion of lipoprotein lipase from macrophages. (1991) (28)
- Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study (2019) (28)
- Apoptotic cell death in atherosclerotic plaques of hyperlipidemic knockout mice. (1997) (28)
- Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes. (2003) (27)
- Overexpression of human lipoprotein lipase increases hormone-sensitive lipase activity in adipose tissue of mice. (1995) (27)
- Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats. (2003) (27)
- Spironolactone Suppresses Peritubular Capillary Loss and Prevents Deoxycorticosterone Acetate/Salt-Induced Tubulointerstitial Fibrosis (2008) (27)
- Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance (2018) (27)
- Sterol Regulatory Element-binding Proteins Activate Insulin Gene Promoter Directly and Indirectly through Synergy with BETA2/E47* (2005) (27)
- Waist Circumference as a Cardiovascular and Metabolic Risk in Japanese Patients With Type 2 Diabetes (2009) (26)
- Cross-Talk between Peroxisome Proliferator-Activated Receptor ( PPAR ) and Liver X Receptor ( LXR ) in Nutritional Regulation of Fatty Acid Metabolism (2003) (26)
- Transcription factor PU.1 mediates induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypic change to phagocytic cells (1996) (26)
- A platelet factor stimulating the proliferation of vascular endothelial cells. Partial purification and characterization. (1985) (26)
- Apolipoprotein E Polymorphism Is Associated With Plasma Cholesterol Response in a 7-day Hospitalization Study for Metabolic and Dietary Control in NIDDM (1993) (26)
- The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages. (2001) (25)
- Unilateral adrenalectomy improves insulin resistance and diabetes mellitus in a patient with ACTH-independent macronodular adrenal hyperplasia. (2003) (25)
- Cross-sectional association between BMI, glycemic control and energy intake in Japanese patients with type 2 diabetes. Analysis from the Japan Diabetes Complications Study. (2007) (25)
- The enhanced cellular uptake of very-low-density lipoprotein enriched in apolipoprotein E. (1991) (24)
- The Effect of Antihypertensive Drugs on Endothelial Function as Assessed by Flow-Mediated Vasodilation in Hypertensive Patients (2012) (24)
- Critical role of neutral cholesteryl ester hydrolase 1 in cholesteryl ester hydrolysis in murine macrophages[S] (2014) (24)
- A truncated species of apolipoprotein B (B-38.7) in a patient with homozygous hypobetalipoproteinemia associated with diabetes mellitus. (1998) (23)
- Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus (2014) (23)
- Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study (2020) (22)
- Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. (2014) (22)
- New Insights on the Simultaneous Assessment of Insulin Sensitivity and β-Cell Function With the HOMA2 Method (2007) (22)
- The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus. (2012) (22)
- Peripheral circadian rhythms in the liver and white adipose tissue of mice are attenuated by constant light and restored by time-restricted feeding (2020) (22)
- Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination (2019) (21)
- Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. (1998) (21)
- Hyperglycemia enhances VSMC proliferation with NF-κB activation by angiotensin II and E2F-1 augmentation by growth factors (2002) (21)
- Role of Monocyte Colony-Stimulating Factor in Foam Cell Generation (1992) (21)
- Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats. (2006) (20)
- Dual regulation of mouse D 5-and D 6-desaturase gene expression by SREBP-1 and PPAR a (2002) (20)
- Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study. (2017) (20)
- Hyperlipidaemia in patients with hypopituitarism. (1985) (20)
- Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages (2018) (20)
- Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2013) (19)
- Effects of hormone-sensitive lipase disruption on cardiac energy metabolism in response to fasting and refeeding. (2009) (19)
- Anti-atherosclerotic Activity of Triacsin C, an Acyl-CoA Synthetase Inhibitor (2008) (19)
- Diagnosis of Atherosclerosis (2014) (19)
- New Pyripyropene A Derivatives, Highly SOAT2-Selective Inhibitors, Improve Hypercholesterolemia and Atherosclerosis in Atherogenic Mouse Models (2015) (19)
- Lipoprotein Subfractions Highly Associated With Renal Damage in Familial Lecithin: Cholesterol Acyltransferase Deficiency (2014) (18)
- Cross-sectional survey to assess the status of lipid management in high-risk patients with dyslipidemia: clinical impact of combination therapy with ezetimibe. (2012) (18)
- Roles of immunoglobulin‐like loops of junctional cell adhesion molecule 4; involvement in the subcellular localization and the cell adhesion (2003) (18)
- Comparative study of atherosclerotic parameters in Mongolian and Japanese patients with hypertension and diabetes mellitus. (2010) (17)
- Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes. (2006) (17)
- Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus. (2010) (17)
- Cholesterol-free diet with a high ratio of polyunsaturated to saturated fatty acids in heterozygous familial hypercholesterolemia: significant lowering effect on plasma cholesterol. (1990) (17)
- The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients--multicenter trial. (2013) (17)
- Disruption of Autosomal Recessive Hypercholesterolemia Gene Shows Different Phenotype In Vitro and In Vivo (2004) (16)
- Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2014) (16)
- Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects. (2004) (16)
- Myeloid HMG-CoA Reductase Determines Adipose Tissue Inflammation, Insulin Resistance, and Hepatic Steatosis in Diet-Induced Obese Mice (2019) (16)
- Decrease in Urinary Excretion of Aquaporin-2 Associated with Impaired Urinary Concentrating Ability in Diabetic Nephropathy (2002) (15)
- Management of type IIb dyslipidemia. (2012) (15)
- Cardio-Ankle Vascular Index and Indices of Diabetic Polyneuropathy in Patients with Type 2 Diabetes (2017) (15)
- Low well‐being, cognitive impairment and visual impairment associated with functional disabilities in elderly Japanese patients with diabetes mellitus (2004) (15)
- Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow (2018) (14)
- Index of glucose effectiveness derived from oral glucose tolerance test (2012) (14)
- Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2013) (14)
- Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus. (1989) (14)
- HLA-DR-DQ haplotype in rapid-onset type 1 diabetes in Japanese. (2003) (14)
- Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins. (1989) (13)
- Immunohistochemical localization of apolipoprotein E in atherosclerotic lesions of the aorta and coronary arteries. (1986) (13)
- Lipoprotein lipase in mouse peritoneal macrophages: the effects of insulin and dexamethasone. (1986) (13)
- Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement. (2011) (12)
- Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver[S] (2015) (12)
- Effect of tumor necrosis factor/cachectin on the activity of the low density lipoprotein receptor on human skin fibroblasts. (1990) (12)
- Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study (2018) (12)
- P-gp-induced modulation of regulatory volume increase occurs via PKC in mouse proximal tubule. (2002) (12)
- The long-term effects of self-management education for patients with type 2 diabetes on glycemic control: response to Norris et al. (2002) (12)
- The Relationship between Urinary 8-Hydroxydeoxyguanosine and Metabolic Risk Factors in Asymptomatic Subjects (2011) (12)
- Early onset insulin‐dependent diabetes mellitus as an initial manifestation of aceruloplasminaemia (2006) (12)
- Clinical Features Associated With the Homozygous Trp64Arg Mutation of the β3-Adrenergic Receptor (1998) (12)
- Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. (2013) (12)
- β-Cell–Specific Deletion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) Reductase Causes Overt Diabetes due to Reduction of β-Cell Mass and Impaired Insulin Secretion (2020) (11)
- Neuromedin U facilitates oxytocin release from the pituitary via &bgr; adrenoceptors (2003) (11)
- Arterial wall elasticity measured using the phased tracking method and atherosclerotic risk factors in patients with type 2 diabetes. (2013) (11)
- High-cholesterol diet-induced lipoproteins stimulate lipoprotein lipase secretion in cultured rat alveolar macrophages. (1987) (11)
- Plasma apolipoprotein CII levels in hypertriglyceridemia. (1986) (11)
- Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice. (2001) (11)
- Induction of ABCA1 by overexpression of hormone-sensitive lipase in macrophages. (2008) (11)
- Adrenal neutral cholesteryl ester hydrolase: identification, subcellular distribution, and sex differences. (2002) (10)
- Apolipoprotein E metabolism in sciatic nerves of diabetic rats. Implication for diabetic neuropathy. (1993) (10)
- Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypes (1998) (10)
- High Mobility Group Protein-B1 Interacts with Sterol Regulatory Element-binding Proteins to Enhance Their DNA Binding* (2005) (10)
- Suppression of neutral cholesterol ester hydrolase activity by antisense DNA of hormone-sensitive lipase. (1997) (10)
- Possible involvement of PCSK9 overproduction in hyperlipoproteinemia associated with hepatocellular carcinoma: A case report. (2016) (10)
- Role of Lipoprotein Lipase (1998) (10)
- Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications Study. (2016) (10)
- Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan. (1997) (10)
- Vasoactive intestinal peptide and cytokines enhance stem cell factor production from epidermal keratinocytes DJM-1. (2002) (10)
- [Knockout mouse]. (2001) (10)
- Absolute risk of cardiovascular disease and lipid management targets. (2013) (9)
- Small Fibre Neuropathy Is Associated With Impaired Vascular Endothelial Function in Patients With Type 2 Diabetes (2021) (9)
- Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study (2021) (9)
- Diabetic lipemia with eruptive xanthomatosis in a lean young female with apolipoprotein E4/4. (2005) (9)
- Down-regulation of hepatic LDL receptor protein and messenger RNA in fasted rabbits. (1988) (9)
- Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus. (2012) (9)
- Cholesterol Reduction and Atherosclerosis Inhibition by Bezafibrate in Low-Density Lipoprotein Receptor Knockout Mice (2008) (9)
- Disruption of Cholesterol 7α-Hydroxylase Gene in Mice (1996) (9)
- Treatment B) Drug Therapy (2013) (9)
- Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells. (2002) (8)
- Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study (2021) (8)
- Familial hypercholesterolemia. (2014) (8)
- Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus. (2013) (8)
- A kindred of familial acromegaly without evidence for linkage to MEN-1 locus. (2002) (8)
- Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials (2021) (8)
- A Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide. (2000) (8)
- Apolipoprotein E prevents the progression of atherosclerosis in WHHL rabbits and transgenic mice (1994) (8)
- A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Indicated Significant Improvement in Glycemic and Liver Function-related Parameters (2018) (8)
- Current Diagnosis and Management of Abetalipoproteinemia (2021) (8)
- Current Diagnosis and Management of Primary Chylomicronemia (2021) (8)
- Abstract 13374: Efficacy and Safety of K-877, a Potent and Selective PPAR-α Modulator (SPPARMα), in Combination With Statins in Japanese Patients With Dyslipidemia (2015) (7)
- Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lep ob/ob mice. (2009) (7)
- Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering (2017) (7)
- Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study (2021) (7)
- Esterification of 4β-hydroxycholesterol and other oxysterols in human plasma occurs independently of LCAT (2020) (7)
- The correlation between CVR-R and carotid atherosclerosis in type 2 diabetes mellitus patients with diabetic neuropathy. (2010) (7)
- Cloning and structural analysis of the mouse apolipoprotein B mRNA editing protein gene. (1995) (7)
- Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiency. (2011) (7)
- Synergistic effects of transforming growth factor‐β on the expression of c‐fms, macrophage colony‐stimulating factor receptor gene, in vascular smooth muscle cells (1996) (7)
- Regulation of hormone-sensitive lipase in islets. (2007) (7)
- Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study (2020) (7)
- The correlation between the cardio-ankle vascular index (CAVI) and serum amyloid A in asymptomatic Japanese subjects (2012) (7)
- Clinical features associated with the homozygous Trp64Arg mutation of the beta3-adrenergic receptor: no evidence for its association with obesity in Japanese. (1998) (6)
- Insulin and Proinsulin Dynamics Progressively Deteriorate From Within the Normal Range Toward Impaired Glucose Tolerance (2020) (6)
- A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement (2018) (6)
- Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides. (2006) (6)
- Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency (2019) (6)
- Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate (2021) (6)
- Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitus (2014) (6)
- Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional study (2012) (5)
- Long‐term efficacy of the sodium–glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome (2020) (5)
- Diet-induced hypercholesterolemia in mice (1990) (5)
- Tetsuya Effects on CD 36 Expression and HDL Knockout Mice : Pleiotropic − Troglitazone Inhibits Atherosclerosis in Apolipoprotein (2001) (5)
- Abstract 15652: Comparison of the Novel Peroxisome Proliferator-Activated Receptor Alpha Agonist K-877 and Fenofibrate on High-Density Lipoprotein Subclass Distribution Determined by High-Performance Liquid Chromatography in Patients With Dyslipidemia (2013) (5)
- Successful pregnancy outcomes in a patient with type A insulin resistance syndrome (2015) (5)
- Hepatic insulin sensitivity assessed by integrated model of hepatic and peripheral glucose regulation. (2009) (5)
- The release of hepatic triglyceride lipase from rat monolayered hepatocytes in primary culture. (1990) (5)
- Effects of apo E deficiency on plasma lipid levels in mice lacking APOBEC-1. (1997) (5)
- Urinary Excretion of Aquaporin-2 Water Channel in Diabetic Ketoacidosis (2002) (5)
- HMG-CoA Reductase Deficiency in Mice 1 Early embryonic lethality caused by targeted disruption of the HMG-CoA reductase gene (2003) (5)
- Severe hypoglycaemia is a major predictor of incident diabetic retinopathy in Japanese patients with type 2 diabetes. (2017) (5)
- Obesity is a critical risk factor for worsening of glucose tolerance in a family with the mutant insulin receptor. (2002) (4)
- Resistance to high fat diet-induced obesity associated with altered expression of adipose specific genes in hormone-sensitive lipase deficient mice Authors (2003) (4)
- The Vascular Renin-Angiotensin System as a Possible Source of Vascular Inflammation in Fructose-Fed Rats (2007) (4)
- Transgenic Mouse and Gene Therapy (1996) (4)
- Abstract 10718: Efficacy and Safety of K-877, a Potent and Selective PPAR-a Agonist, in Japanese Patients With Dyslipidemia (2013) (4)
- Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene. (2013) (4)
- Overexpression of low density lipoprotein receptor on Chinese hamster ovary cells generates foam cells. (1991) (4)
- Case of acute‐onset type 1 diabetes induced by long‐term immunotherapy with nivolumab in a patient with mucosal melanoma (2019) (4)
- Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells (2019) (4)
- Low hemoglobin A1c and low body mass index are associated with dementia and activities of daily living disability among Japanese nursing home residents with diabetes (2019) (4)
- CD36 deficiency and insulin resistance (2001) (3)
- Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitus. (2012) (3)
- Guidance for the diagnosis and treatment of hypolipidemia disorders. (2022) (3)
- Background to discuss guidelines for control of plasma HDL-cholesterol in Japan. (2012) (3)
- Chronic inhibitory effect of insulin on plasma lipid concentrations in rats with transplanted pancreas. (2000) (3)
- Effect of exogenous apo E on the cellular binding of lipoproteins. (1990) (3)
- Weaning stage hyperglycemia induces glucose-insensitivity in arcuate POMC neurons and hyperphagia in type 2 diabetic GK rats (2018) (3)
- The Anti-atherogenic Activity of Beauveriolide Derivative BVD327, a Sterol O-Acyltransferase 2-Selective Inhibitor, in Apolipoprotein E Knockout Mice. (2020) (3)
- Requirement for hypertension and hyperlipidemia medication in U.S. and Japanese patients with diabetes. (2004) (3)
- [Abnormalities of the enzymes involved in lipid metabolism]. (2007) (2)
- Other high-risk conditions. (2013) (2)
- Abstract 17336: Marked Increase of Plasma Fibroblast Growth Factor 21 in Dyslipidemic Patients Treated With K-877, a Novel Highly Potent and Specific Peroxisome Proliferator-Activated Receptor Alpha Agonist (2013) (2)
- [Lipoprotein(a) [Lp(a)]]. (2001) (2)
- Glimepiride and Serum Adiponectin Level in Type 2 Diabetic Subjects: Response to Yoshioka, Yoshida, and Yoshikawa (2003) (2)
- Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia (2020) (2)
- Effects of Selective PPARα Modulator K-877 on Particle Numbers of Lipoprotein Subclasses in Dyslipidemic Patients: Analysis by GP-HPLC and NMR Lipoprofile 2 and 3 (2018) (2)
- A novel SOX10 nonsense mutation in a patient with Kallmann syndrome and Waardenburg syndrome (2021) (2)
- Characterization of monoclonal anti-rabbit apolipoprotein E antibodies and chemical composition of lipoproteins separated by anti-apolipoprotein E immuno-affinity chromatography. (1991) (2)
- [Perspective of gene therapy in hyperlipoproteinemia]. (1994) (2)
- Response to the Letter by Ghosh (2011) (2)
- Sterol Regulatory Element-binding Proteins Activate Insulin Gene Promoter Directly and Indirectly through Synergy with BETA 2 / E 47 * (2005) (2)
- Validation of Particle Numbers of Lipoproteins by Gel Permeation Chromatography: Comparison with NMR Lipoprofile 2 (LipoScience) and Lipoprofile 3 (LabCorp) (2018) (2)
- Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. (2014) (2)
- [Low density lipoprotein receptor gene]. (2006) (2)
- Influence of atorvastatin on serum amyloid A-low density lipoprotein complex in hypercholesterolemic patients. (2012) (2)
- Long-term Pemafibrate Treatment Was Well Tolerated in Patients with Dyslipidemia Including Those with Kidney Dysfunction (2018) (2)
- Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design (2021) (2)
- Postloading insulinemia is independently associated with arterial stiffness in young Japanese persons (2021) (2)
- Efficacy of Pemafibrate on Atherogenic Dyslipidemia: Results of a Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Compared with Placebo (2018) (2)
- Relationship between upper limb peripheral artery stiffness using the radial artery and atherosclerotic parameters (2009) (2)
- [Pathogenesis of atherosclerosis in metabolic syndrome]. (2006) (1)
- AAA-ATPase valosin-containing protein binds the transcription factor SREBP1 and promotes its proteolytic activation by rhomboid protease RHBDL4 (2022) (1)
- Leptin sensitizing effect of 1,3-butanediol and its potential mechanism (2021) (1)
- Comparison of the effects of frequent versus conventional nutritional interventions in patients with type 2 diabetes mellitus: A randomized, controlled trial (2021) (1)
- Improved Glycemic Control in a Diabetic Patient After Discontinuation of Allopurinol Administration (1998) (1)
- Special Report Guidelines for the Management of Familial Hypercholesterolemia (2012) (1)
- [LDL receptor activity]. (2004) (1)
- Metabolic syndrome. (2020) (1)
- Normal plasma apoB48 despite the virtual absence of apoB100 in a compound heterozygote with novel mutations in the MTTP gene. (2021) (1)
- Cerebrovascular diseases: Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version (2014) (1)
- [Guideline for management of lipid metabolism]. (2002) (1)
- Dissection of the chylomicron remnant clearance pathway (1994) (1)
- DHCR7 as a novel regulator of ferroptosis in hepatocytes (2022) (1)
- [Functions of enzymes involved in lipid metabolism]. (2007) (1)
- MON-210 Role of Female Gender and Subcutaneous Fat in the Positive Association of Obesity with Idiopathic Hyperaldosteronism (2020) (1)
- Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings of 18F-THK5351 Positron Emission Tomography: A Case Report (2021) (1)
- [Management of blood glucose--target of the management and its practice]. (2006) (1)
- Cholesterol‐Free Diet in Heterozygous Familial Hypercholesterolemia (1990) (1)
- Predictors of response to ipragliflozin treatment in patients with type 2 diabetes mellitus. (2016) (1)
- Ankle-brachial index and eicosapentaenoic acid/arachidonic acid ratio in smokers with type 2 diabetes mellitus (2016) (1)
- A neonatal case of apolipoprotein C-II deficiency (1989) (1)
- Augmentation by heparin of endothelial cell proliferation in vitro (1985) (1)
- Enhanced synthesis and secretion of apolipoprotein E from sciatic nerves of streptozotocin-induced diabetic rats after injury. (1988) (1)
- [Acquired hypertriglyceridemia]. (2013) (1)
- Effect of Monocyte Colony‐Stimulating Factor (M‐CSF) on Lipoprotein Metabolism (1990) (1)
- Urinary Protein as a Marker for Systolic Blood Pressure Reduction in Patients with Type 2 Diabetes Mellitus Participating in an In-Hospital Diabetes Education Program (2011) (1)
- 53 Involvement in the Pathogenesis of Fatty Liver Disease * (2004) (1)
- Erythropoietin mimetic peptides and the future (2000) (0)
- [Common carotid arterial diameter and coronary artery disease]. (2011) (0)
- Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019 (2022) (0)
- Phenotyping of the TEP1 Knock Out Mice (1998) (0)
- Hepatocyte HMGCR is essential for the survival of mice , and its abrogation elicits hepatic steatosis with jaundice and hypoglycemia (0)
- Comparative Studies of Atherosclerosis by Using Genetically Engineered Murine Models (1997) (0)
- An Observational Study on the Clinical and Nutritional Factors Determining the Kidney Function at One Year after Transplantation (2018) (0)
- A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Showed No Significant Increase in Incidence of Adverse Events Compared with Placebo (2018) (0)
- Abstract 5520: Lethal Hepatic Failure with Steatosis in Liver-Sepecific 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Knockout Mice (2008) (0)
- Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease? (2022) (0)
- Abstract 12384: Novel Approach to Residual Risk, K-877, a Potent and Selective PPAR-α Modulator (SPPARMα), Added-on to Pitavastatin in Japanese Patients With Dyslipidemia (2015) (0)
- F067 Dominant role of low density lipoprotein receptor (LDLR) pathway for β-VLDL uptake in mouse peritoneal macrophages: a study using lipoproteins and macrophages from LDLR and apolipoprotein E knockout mice (1998) (0)
- Abstract 19830: Role of Nlrp3 Inflammasomes in Aggravation of Atherosclerosis and Xanthoma in Hyperlipidemic Mice Lacking Acyl Coa Cholesterol Acyltransferase 1 (acat1) in Bone Marrow (2017) (0)
- Abstract 5475: A Novel Lipase, Neutral Cholesteryl Ester Hydrolase, is a Major Regulator of Neutral Cholesteryl Ester Hydrolysis in Murine Macrophages. (2008) (0)
- Abstract 19406: Amelioration of Streptozotocin-Induced Diabetic Hypertriglyceridemia in the Absence of Hormone-Sensitive Lipase (2016) (0)
- OJ-196 AAV-mediated IL-10-gene Transfer into Apolipoprotein E-deficient Mice Inhibits Atherosclerosis through Anti-inflammatory and Cholesterol-lowering Effects(Atherosclerosis, Basic 2 (IHD) : OJ22)(Oral Presentation (Japanese)) (2004) (0)
- Diet and Hyperlipidemia in Transgenic Mouse: ―トランスジェニック動物より― (1996) (0)
- Genetic Manipulation of Lipoprotein Receptors: Implications for Lipid Metabolism and Atherosclerosis (1995) (0)
- Apoptosis in Atherosclerosis: Induction of Apoptosis by Oxidized Low Density Lipoprotein and Oxysterols (2000) (0)
- Role of ApoE in the Metabolism of Triglyceride-rich Lipoproteins: Transgenic Mice Overexpressing Apolipoprotein E: ―アポEを過剰発現するトランスジェニックマウス― (1995) (0)
- Abstract 11508: Macrophage-Specific Disruption of HMG-CoA Reductase Inhibited the Development of Atherosclerosis (2011) (0)
- 187. Adeno-Associated Virus Vector-Mediated Soluble Flt-1 Gene Transfer Prevents Diabetic Retinopathy in Spontaneously Diabetic Rat Model (2004) (0)
- Abstract 18320: A Novel Tandem Duplication Containing a Noncoding Exon of the APOC2 Gene Causes Chylomicronemia With Markedly Reduced Levels of Plasma Apolipoprotein C-II (2016) (0)
- Two-Compartment-Labeled Minimal Model Sensitivity, and Endogenous Glucose Production in Healthy Humans Estimated by a Effect of Moderate Exercise Training on Peripheral Glucose Effectiveness, Insulin (2015) (0)
- 4. Management of Disorders of Lipoprotein Metabolism-Update- (2018) (0)
- 1P-0130 Genetic analysis of the spontaneously hypertensive rats (SHR), an animal model of metabolic syndrome (2003) (0)
- [Recent trend in the research of hyperlipidemia in Japan. Significant role of apo E in lipoprotein metabolism in rabbits]. (1989) (0)
- [Gene therapy for hyperlipoproteinemia]. (2001) (0)
- Chronic kidney disease. (2014) (0)
- Abstract 14137: A Newly Identified Case of Apolipoprotein C-II Deficiency Associated with Reduced Transcriptional Activity (2010) (0)
- Contents, Supplement 1, 1990 (1990) (0)
- Lipolysis and degradation of VLDL from a patient with apo-CII deficiency by macrophages (1987) (0)
- Defeating the Invisible Enemies (2017) (0)
- Biochemical characterization of vascular endothelial cell proliferation factor derived from human platelets (1985) (0)
- SUN-096 Hypothalamic ATP Has a Crucial Role in the Pathogenesis of Leptin Resistance: A Potential Mechanism for the Amelioration of Leptin Resistance by Celastrol and Withaferin A (2019) (0)
- 4.W21.3 Transgenic dissection of atherogenic profiles of plasma lipoproteins and arterial wall metabolism (1997) (0)
- Abstract 13138: In vivo Efficacy of PRD017, a New Pyripyropene a Derivative and Highly Potent SOAT2-Selective Inhibitor, in Apolipoprotein E KO Mice (2012) (0)
- Title: Large-scale replication analysis of loci associated with lipid concentrations in a (2017) (0)
- Diabetic family history in young Japanese persons with normal glucose tolerance associates with k-means clustering of glucose response to oral glucose load, insulinogenic index and Matsuda index (2022) (0)
- Low density lipoprotein receptor knockout mouse (1994) (0)
- High-level cholesterol as a rate-limiting factor of myelin membrane growth (2005) (0)
- Hypophosphatasia : a case report (1979) (0)
- [Gene therapy of hyperlipoproteinemia]. (1999) (0)
- Committee Report 16 Women (2014) (0)
- Current Diagnosis and Management of Primary Chylomicronemia Advance Publication Journal of Atherosclerosis and Thrombosis (2021) (0)
- 中国人与日本人β3肾上腺素能受体基因Trp64Arg突变的比较 (2000) (0)
- Apolipoprotein E and Lipoprotein Lipase Secreted From Human Monocyte-Derived Macrophages Modulate the Uptake of Very Low Density Lipoproteins (1991) (0)
- The elderly. (2014) (0)
- Abstract 9012: Ablation of Neutral Cholesterol Ester Hydrolase 1 Accelerates Oxysterol-induced Macrophage Apoptosis by Aggravating Endoplasmic Reticulum Stress. (2010) (0)
- Symposium on recent trend in the research of hyperlipidemia in Japan. Supplement. Significant role of apo E in lipoprotein metabolism in rabbits. (1989) (0)
- [Significance of lipoprotein lipase analysis in clinical tests]. (1989) (0)
- A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide (2021) (0)
- Pemafibrate improved postprandial TG, Reml-C and ApoB48 in patients with type 2 diabetes (T2D) and hypertriglyceridemia: A post-hoc analysis of the phase 3 clinical trial (2022) (0)
- Statements. (2021) (0)
- Cerebrovascular diseases. (2014) (0)
- [Apolipoprotein genes]. (1997) (0)
- Abstract 19334: Pyripyropene A, a Selective Inhibitor of Acyl-CoA:cholesterol Acyltransferase 2, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia (2010) (0)
- The Measurement of Proinsulin Level, But Not Insulin, is Useful for Diagnosis of Insulinoma. (2010) (0)
- Supplementary. Significant Role of Apo E in Lipoprotein Metabolism in Rabbits (1989) (0)
- Transgenic mice: A new approach to lipoprotein metabolism and atherogenesis (1992) (0)
- Skin eruption, fever and hypercalcemia: malignant reticulosis with marked dermal and bone lesions. (1975) (0)
- Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia (2022) (0)
- Loss of myeloid lipoprotein lipase exacerbates adipose tissue fibrosis with collagen VI deposition and hyperlipidemia in leptin-deficient obese mice (2022) (0)
- We-W37:3 Autosomal recessive hypercholesterolemia (ARH) knockout mouse has delayed catabolism of LDL in vivo but normal internalization of LDL in vitro (2006) (0)
- Glucose Effectiveness Decreases in Relationship to a Subtle Worsening of Metabolic Parameters in Young Japanese with Normal Glucose Tolerance. (2021) (0)
- [A case of polymyositis associated with hypertriglyceridemia due to decline of lipoprotein lipase activity]. (1984) (0)
- Abstract 1614: Neutral Cholesterol Ester Hydrolase is Essential for Cholesterol Removal in Human Macrophages and Atherosclerosis (2009) (0)
- SREBPs activate insulin gene promoter directly and indirectly through synergy with BETA2/E47. (2005) (0)
- Committee Report 14 Cerebrovascular Diseases (2014) (0)
- ADRENAL-HYPERTENSION Role of Female Gender and Subcutaneous Fat in the Positive Association of Obesity with Idiopathic Hyperaldosteronism (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shun Ishibashi?
Shun Ishibashi is affiliated with the following schools:
